Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 272 for “"bromodomain"”.
-
Therapeutic Potential of Bromodomain Targeting – Development of Anti-Inflammatory Bromodomain Inhibitors & Tumour Targeting SelecPROTACs
Bromodomains (BRDs) are protein modules acting as “readers” of the histone code by recognising acetylated lysines (KAc) and thereby contributing to the regulation of gene expression. Despite the well-established contributions of some BRDs to cancer, diabetes and various other diseases, the …
-
Global chemoproteomic profiling of bromodomain inhibitors
Bromodomain-containing proteins (BCPs) are epigenetic readers that regulate gene expression and play key roles in many diseases including cancer, making them prime targets for drug discovery. While several high-quality chemical probes and inhibitors have been developed for various bromodomains, …
-
Developing inhibitors of bromodomain-histone interactions
… acetyl-lysine recognition domain, the bromodomain. Small-molecule inhibitors of bromodomain-histone interactions can greatly assist studies into the functions of bromodomain-containing proteins, and show promise as treatments for several diseases, including cancers. Herein I describe …
-
Development of ligands for the TRIM33 bromodomain
… pathways. It contains a tandem PHD finger-bromodomain cassette, which recognises methylated and acetylated lysine residues on histone proteins. The aim of this project was to develop ligands for the TRIM33 bromodomain, which can be used as chemical tools to further validate the role of …
-
Development of ligands to target bromodomain-histone interactions
… modification recognised by the bromodomain, a protein module that forms part of multi-component complexes affecting transcription. This interaction plays fundamental cellular roles, and shows association with particular diseases including inflammation and cancer. The biological …
-
Developing small molecule inhibitors of bromodomain-histone interactions
<p>Bromodomains, protein modules found in 46 human chromatin-associated proteins, bind to acetylated lysine residues (KAc), and modulate the formation of complex protein scaffolds, which are often involved in transcription. The work in this dissertation focuses on the development of small molecule …
-
The design and synthesis of small molecule bromodomain inhibitors
… limit their use. As the BET family consists of 4 bromodomain containing proteins (BRD2, 3, 4, and T), each of which contain 2 bromodomains (a BD1 and a BD2 domain), there is the potential that inhibitors which selectively target a single protein or domain, will retain efficacy and mitigate the …
-
Investigating bromodomain proteins as targets for antileishmanial drug discovery
… so new antileishmanials are urgently needed. Bromodomain inhibitors have shown huge potential for the treatment of other diseases, and may also present an attractive drug target in Leishmania. Five bromodomain factor (BDF) proteins are found in Leishmania which are essential for promastigote …
-
Double bromodomain proteins as regulators of lymphopoiesis and inflammation
… is associated with immune diseases and cancer. Bromodomains are highly conserved protein structures that bind acetylated lysines of nucleosomal histones. Among the diverse group of all bromodomain-containing proteins, the members of BET (bromodomain extra terminal) family- Brd2, Brd3, Brd4 and …
-
Role of bromodomain containing proteins in the DNA damage response
… signaling and repairing DNA damage. The bromodomain (BRD) containing protein is the primary reader of acetylation. Thus, BRD proteins represent attractive candidates for reading damaged chromatin to mediate genome-epigenome integrity. In the first part of this project, I performed a …
-
Synthesis and biological evaluation of novel small molecule bromodomain inhibitors
… without changing the primary DNA sequence. Bromodomain-containing proteins are responsible for recognising acetylated residues on histone tails, recruiting transcriptional machinery and thus facilitating gene transcription. Small molecule bromodomain inhibitors prevent this recognition, thus …
-
BET Bromodomain Inhibition as an Approach for Treatment of Cholangiocarcinoma
… this hypothesis has not been addressed. The bromodomain and extraterminal domain (BET) family of proteins are epigenetic adapter proteins which promote the transcription of genes including MYC. We previously reported that the BET inhibitor JQ1 lead to significant growth reduction and …
-
In silico tools to aid medicinal chemistry: optimising bromodomain inhibitors
<p>Development of ligands for bromodomains has expanded our understanding of gene regulation and epigenetic links to disease. These acetylated lysine ‘reader’ domains are found within larger macromolecules that are involved in gene transcription and degradation. This thesis looks to employ a range …
-
Development of small molecule inhibitors of the bromodomain-histone interaction
<p>Bromodomains bind to acetylated lysine residues 1 to mediate a wide range of biological processes, including the assembly of transcriptional machinery at modified histones. This thesis describes the design of small molecule inhibitors of bromodomains, with particular focus on the bromodomain of …
-
Discovery of epigenetic probes against the bromodomain family of proteins
… elucidating the biochemical roles of proteins. Bromodomains are protein-interaction modules found in a family of proteins implicated in the epigenetic regulation of transcription; however, the individual roles remain unknown for many bromodomain proteins, without potent and selective ligands …
-
Molecular targeting of lymphoma through bromodomain inhibition and induction of apoptosis
… novel therapies for lymphomas. We employed novel bromodomain and extraterminal (BET) inhibitors, PLX51107 and PLX2853, in Eμ-myc lymphoma cells and human lymphoma cells to induce apoptosis. We determined that this was largely through BIM upregulation, a key pro-apoptotic protein. We concluded that …
-
Development and Cellular Evaluation of Selective N-Terminal BET Bromodomain Inhibitors
… become drivers of disease. In the case of bromodomains, which recognize N-acetylated-lysine, developing domain selective inhibitors has been a significant challenge to medicinal chemists. However, recent development of inhibitors with domain-selectivity within the Bromodomain and Extra …
-
Development of peptide-based 19F MRI agents and BPTF-bromodomain inhibitors
… first reported small molecule inhibitor of the bromodomain of a protein called BPTF, was discovered in the Pomerantz lab in 2015. As BPTF is a relatively understudied protein, there exists a need to improve the potency of AU1 as a probe for the various functions of its bromodomain, as it has …
Page 1 of 14